Visfatin在结直肠癌中的表达及其意义(2)
参考文献
[1]JayasekaraH， EnglishDR ，HaydonA，etal. Associations of alcoholintake ，smoking，Physical activity and obesity with survival following colorectal cancer diagnosis by-stage， anatomic site and tumor molecular subtype[J].IntJ Cancer，2018，142(2)：238-250
[2]Chen M1， Wang Y1， Li Y2，etal. Association of plasma visfatin with risk of colorectal cancer： An observational study of Chinese patients. Asia Pac J Clin Oncol. 2016 Mar；12(1)：e65-74 doi： 101111/ajco.12090
[3]孫一帆. Visfatin与消化系统肿瘤的关系研究进展[J]. 检验医学与临床，2016，13(16)：2388-2390 Doi：103969/j.issn.1672-9455201616063
[4]Mohammadi M1， Zarghami N2， Hedayati M1， et al. Synergistic Effects of Resistin and Visfatin as Adipocyte Derived Hormones on Telomerase Gene Expression in AGS Gastric Cancer Cell Line.Acta Med Iran. 2017 Oct；55(10)：621-627
[5]Moi SH#1， Lee YC#2，3， Chuang LY4， et al. Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression.Cancer Cell Int. 2018 Feb 9；18：19 doi： 101186/s12935-018-0517-z.
[6]Cymbaluk-Poska A1， Chudecka-Gaz A1， Pius-Sadowska E2， et al. Circulating Serum Level of Visfatin in Patients with Endometrial Cancer. Biomed Res Int. 2018 Jan 4；2018：8576179 doi： 101155/2018/8576179, 百拇医药(荣玮 徐晨 李雪松)
[1]JayasekaraH， EnglishDR ，HaydonA，etal. Associations of alcoholintake ，smoking，Physical activity and obesity with survival following colorectal cancer diagnosis by-stage， anatomic site and tumor molecular subtype[J].IntJ Cancer，2018，142(2)：238-250
[2]Chen M1， Wang Y1， Li Y2，etal. Association of plasma visfatin with risk of colorectal cancer： An observational study of Chinese patients. Asia Pac J Clin Oncol. 2016 Mar；12(1)：e65-74 doi： 101111/ajco.12090
[3]孫一帆. Visfatin与消化系统肿瘤的关系研究进展[J]. 检验医学与临床，2016，13(16)：2388-2390 Doi：103969/j.issn.1672-9455201616063
[4]Mohammadi M1， Zarghami N2， Hedayati M1， et al. Synergistic Effects of Resistin and Visfatin as Adipocyte Derived Hormones on Telomerase Gene Expression in AGS Gastric Cancer Cell Line.Acta Med Iran. 2017 Oct；55(10)：621-627
[5]Moi SH#1， Lee YC#2，3， Chuang LY4， et al. Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression.Cancer Cell Int. 2018 Feb 9；18：19 doi： 101186/s12935-018-0517-z.
[6]Cymbaluk-Poska A1， Chudecka-Gaz A1， Pius-Sadowska E2， et al. Circulating Serum Level of Visfatin in Patients with Endometrial Cancer. Biomed Res Int. 2018 Jan 4；2018：8576179 doi： 101155/2018/8576179, 百拇医药(荣玮 徐晨 李雪松)